Russell Frank Company’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Russell Frank Company’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.96M	Buy	30,300 +809	+3%	+$164K	0.01%	1334
2015 Q4	$9.71M	Buy	29,491 +10,723	+57%	+$3.49M	0.02%	904
2015 Q3	$6.05M	Buy	18,768 +8,232	+78%	+$3.62M	0.01%	1163
2015 Q2	$4.2M	Buy	+10,536	New	+$4.48M	0.01%	1523
2014 Q2	–	Sell	-4,730	Closed	-$902K	–	2871
2014 Q1	$902K	Buy	+4,730	New	+$1.45M	﹤0.01%	2132
2013 Q4	–	Sell	-681	Closed	-$115K	–	3102
2013 Q3	$115K	Sell	681 -4,159	-86%	-$669K	﹤0.01%	2924
2013 Q2	$859K	Buy	+4,840	New	+$685K	﹤0.01%	2128

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Frank Company's LUMO Position: Q1 2016 in Review

Russell Frank Company increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 2.7% in Q1 2016, buying an estimated $164K and bringing the position to 30,300 shares worth $4.96M. The position accounts for 0.01% of the portfolio, ranked #1334.

Russell Frank Company first reported a position in LUMO in Q2 2013 and has held it in 7 quarters since. The position peaked at $9.71M in Q4 2015. 139 funds tracked by Wall St. Rank hold LUMO as of Q1 2016.

Russell Frank Company held 30,300 shares of Lumos Pharma, Inc. Common Stock worth $4.96M as of Q1 2016.
Russell Frank Company bought 809 Lumos Pharma, Inc. Common Stock shares in Q1 2016, an estimated $164K.
Lumos Pharma, Inc. Common Stock made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1334 holding.
Russell Frank Company first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 7 quarters since.
Russell Frank Company's Lumos Pharma, Inc. Common Stock position peaked at $9.71M in Q4 2015.
139 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.